ABLA
BAX icon

Alan B. Lancz & Associates’s Baxter International BAX Stock Holding History

Alan B. Lancz & Associates’s Portfolio BAX Stock Details BAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,250
Closed -$250K – 132
2025
Q2 		$250K Hold
8,250
– – 0.25% 113
2025
Q1 		$282K Hold
8,250
– – 0.3% 92
2024
Q4 		$241K Sell
8,250
-450
-5% -$15.2K 0.24% 104
2024
Q3 		$330K Hold
8,700
– – 0.3% 88
2024
Q2 		$291K Buy
+8,700
New +$321K 0.29% 98
2023
Q4 		$344K Sell
8,900
-700
-7% -$24.8K 0.36% 81
2023
Q3 		$362K Sell
9,600
-150
-2% -$6.39K 0.41% 73
2023
Q2 		$444K Hold
9,750
– – 0.48% 65
2023
Q1 		$395K Buy
9,750
+300
+3% +$12.7K 0.41% 74
2022
Q4 		$424K Buy
9,450
+1,500
+19% +$80.6K 0.43% 69
2022
Q3 		$428K Hold
7,950
– – 0.51% 55
2022
Q2 		$466K Sell
7,950
-400
-5% -$29K 0.46% 59
2022
Q1 		$647K Hold
8,350
– – 0.57% 44
2021
Q4 		$717K Buy
+8,350
New +$672K 0.63% 40

Other funds holding BAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Alan B. Lancz & Associates's BAX Position: Q3 2025 in Review

Alan B. Lancz & Associates sold out of Baxter International (BAX) in Q3 2025, closing a stake of 8,250 shares — an estimated $250K sold.

Alan B. Lancz & Associates first reported a position in BAX in Q4 2021 and held it in 14 quarters. The position peaked at $717K in Q4 2021. 734 funds tracked by Wall St. Rank hold BAX as of Q3 2025.

  • Alan B. Lancz & Associates reported no remaining Baxter International position as of Q3 2025 after selling out during the quarter.
  • Alan B. Lancz & Associates sold 8,250 Baxter International shares in Q3 2025, an estimated $250K.
  • Alan B. Lancz & Associates first reported a position in Baxter International in Q4 2021 and held it in 14 quarters.
  • Alan B. Lancz & Associates's Baxter International position peaked at $717K in Q4 2021.
  • 734 funds tracked by Wall St. Rank held Baxter International as of Q3 2025.

Based on Alan B. Lancz & Associates's 13F filing for Q3 2025, filed 13 Nov 2025.